Inventor
Sergey A. Dryga
Inventor
Albuquerque, NM, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes19%
C07KPeptides17%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
B01LChemical or physical laboratory apparatus for general use8%
Y10TTechnical subjects covered by former us classification8%
A61KPreparations for medical, dental or toiletry purposes7%
A61BDiagnosis4%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations4%
G01RMeasuring electric variables3%
PatentTitleYear
11,073,513Separating target analytes using alternating magnetic fields202111,054,384Sensor system and methods of making202110,677,789Analyzing bacteria without culturing202010,416,155Methods for isolating a target analyte from a heterogenous sample201910,000,557Methods for raising antibodies20189,970,931Methods for isolating a target analyte from a heterogenous sample20189,869,671'Analyzing bacteria without culturing'20189,863,940'Methods for isolating a target analyte from a heterogenous sample'20189,804,069'Methods for degrading nucleic acid'20179,696,302'Methods for isolating a target analyte from a heterogeneous sample'20179,671,395'Analyzing bacteria without culturing'20179,562,896'Extracting low concentrations of bacteria from a sample'20179,476,812'Methods for isolating a target analyte from a heterogeneous sample'20169,428,547'Compositions for isolating a target analyte from a heterogeneous sample'20169,389,225'Separating target analytes using alternating magnetic fields'20168,841,104'Methods for isolating a target analyte from a heterogeneous sample'20148,617,533'Multi-antigenic alphavirus replicon particles and methods'20137,425,337'Alphavirus replicon vector systems'20087,419,674'Alpha virus-based cytomegalovirus vaccines'20087,078,218'Alphavirus particles and methods for preparation'20067,045,335'Alphavirus replicon vector systems'20066,783,939'Alphavirus vectors and virosomes with modified HIV genes for use in vaccines'20046,465,634'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis'20026,458,560'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis'20026,451,592'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis'20026,391,632'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002Patents assigned to CHIRON CORP (4)· patent assignee history
2002Based in Fort Collins, CO, US· patent location history
2004–2013Patents assigned to ALPHAVAX INC (5)· patent assignee history
2004–2013Based in Chapel Hill, NC, US· patent location history
2014–2017Patents assigned to DRYGA SERGEY A (5)· patent assignee history
2014–2017Patents assigned to ESCH VICTOR C (5)· patent assignee history
2014–2021Based in Rio Rancho, NM, US· patent location history
2016–2021Based in Albuquerque, NM, US· patent location history
2017–2021Patents assigned to DNAE GROUP HOLDINGS LTD (11)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DNAE GROUP HOLDINGS LTD | 11 | 2017–2021 |
| ALPHAVAX INC | 5 | 2004–2013 |
| DRYGA SERGEY Aself | 5 | 2014–2017 |
| ESCH VICTOR C | 5 | 2014–2017 |
| CHIRON CORP | 4 | 2002 |
Locations
| Location | Patents | Span |
|---|---|---|
| Albuquerque, NM, US | 10 | 2016–2021 |
| Rio Rancho, NM, US | 6 | 2014–2021 |
| Chapel Hill, NC, US | 6 | 2004–2013 |
| Fort Collins, CO, US | 4 | 2002 |